Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3999430 | Urologic Oncology: Seminars and Original Investigations | 2015 | 7 Pages |
Abstract
CN improves OS in patients with mRCC. However, this effect does not seem to be significant for the patients in ECOG performance status groups of 2 to 3 or poor MSKCC prognostic group.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Romain M.D., Géraldine M.D., Ph.D., Alexandre M.D., Maxime M.D., Pierre M.D., Jean-Christophe M.D., Florence M.D., Ph.D., Laurent M.D., Ph.D., Alain M.D., Ph.D., Abdel Rahmene M.D., Ph.D., Gwenaelle M.D., Ph.D., Christine M.D., Ph.D., Laurent M.D.,